Who makes [C-11]6-OH-BTA-1?

[C-11]6-OH-BTA-1 is developed by David Okonkwo, MD, PhD.

What development phase is [C-11]6-OH-BTA-1 in?

[C-11]6-OH-BTA-1 is in Phase 2.

Last reviewed 2026-04-20 · How we verify

[C-11]6-OH-BTA-1

David Okonkwo, MD, PhD · Phase 2 active Small molecule Quality 0/100

At a glance

Generic name	[C-11]6-OH-BTA-1
Also known as	Pittsburgh Compound B
Sponsor	David Okonkwo, MD, PhD
Modality	Small molecule
Phase	Phase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

[C-11]6-OH-BTA-1 CI brief — competitive landscape report
[C-11]6-OH-BTA-1 updates RSS · CI watch RSS
David Okonkwo, MD, PhD portfolio CI